Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vitiligo - Macular Depigmentation”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Very early researchEnrolling By InvitationNCT06880042
What this trial is testing

COMPARISON OF EFFICACY AND SAFETY OF NARROWBAND UVB WITH 0.1% TACROLIMUS VS NARROWBAND UVB WITH 0.005% CALCIPOTRIOL IN TREATMENT OF VITILIGO

Who this might be right for
Vitiligo - Macular DepigmentationTacrolimus
Dr ayesha wahid 60
Not applicableLooking for participantsNCT05635266
What this trial is testing

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Who this might be right for
Age-Related Macular DegenerationAllergiesAlpha-Gal Syndrome+44 more
Sanguine Biosciences 20,000
Large-scale testing (Phase 3)WithdrawnNCT01419964
What this trial is testing

Efficacy and Safety of ACH24 in the Treatment of Vitiligo

Who this might be right for
Vitiligo
Ache Laboratorios Farmaceuticos S.A.
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07016113
What this trial is testing

0.005% Latanoprost Gel for Nonsegmental Vitiligo

Who this might be right for
Vitiligo - Macular Depigmentation
Universitas Padjadjaran 10
Not applicableStudy completedNCT02660320
What this trial is testing

Comparison of the Efficacy of Micro-holes vs. Laser-assisted Dermabrasion, for Repigmenting in Vitiligo Skin

Who this might be right for
Vitiligo - Macular Depigmentation
Centre Hospitalier Universitaire de Nice 5
Not applicableLooking for participantsNCT06491615
What this trial is testing

National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases

Who this might be right for
Inherited Ophthalmic DiseasesHypopigmentation DisorderCorneal Dystrophy+4 more
National Eye Institute (NEI) 1,000